Učitavanje...
Novel combinations to improve hematopoiesis in myelodysplastic syndrome
Myelodysplastic syndrome (MDS) represents a heterogeneous group of clonal hematopoietic disorders, which is characterized by cytopenias in the peripheral blood and bone marrow dysplasia due to ineffective hematopoiesis. Patients with MDS have an increased risk of transformation to acute myeloid leuk...
Spremljeno u:
| Izdano u: | Stem Cell Res Ther |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7083030/ https://ncbi.nlm.nih.gov/pubmed/32197634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-01647-1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|